100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting 'gastcolleges' - Longen 1 $17.10   Add to cart

Summary

Samenvatting 'gastcolleges' - Longen 1

 8 views  0 purchase
  • Course
  • Institution
  • Book

Samenvatting van de gastcolleges als onderdeel van het vak 'Longen 1' gegeven in de 2e Bachelor Geneeskunde aan de UA. Volledige samenvatting gebaseerd op college slides, eigen lesnotities én handboek. Inhoud - gastcolleges - leerstof tijdens Carrousel en practica

Preview 4 out of 122  pages

  • Yes
  • August 23, 2024
  • 122
  • 2023/2024
  • Summary
avatar-seller
Inhoudstafel
De tol van roken & principes van rookstop................................................................................................. 7
De grootteorde van tabakroken..................................................................................................................7
Prevalentie......................................................................................................................................7
Determinanten van preventie..............................................................................................8
Tabaksgebruik - naar een gezond België....................................................................................... 8
Toxicologie van roken.................................................................................................................................9
7000 chemicaliën in een sigaret..................................................................................................... 9
De menselijke tol van tabak roken........................................................................................................... 10
Bradford-Hill criteria voor causaliteit van een associatie tussen blootstelling en ziekte............... 10
Pathofysiologie van roken in het ademhalingsstelsel................................................................... 10
Risico van tabak in vergelijking met andere doodsoorzaken....................................................... 10
Organisatie van rookpreventie..................................................................................................................11
Economische kosten van roken....................................................................................................11
Preventie WHO.............................................................................................................................12

Gedragstherapie bij rookstop..................................................................................................................... 13
Inleiding.................................................................................................................................................... 13
Verslaving.................................................................................................................................................13
Lichamelijk....................................................................................................................................14
Meetapparaten..................................................................................................................14
Stoppen met roken................................................................................................................................... 15
Nicotinevervangers (NRT)............................................................................................................ 15
Gedragsmatige aanpak............................................................................................................................ 15
Fasen van gedrasverandering......................................................................................................15
Gedachten controleren................................................................................................................. 16
5 G’s schema....................................................................................................................16
Belang van gedragsmatige aanpak.............................................................................................. 17
Wat werkt er?........................................................................................................................................... 17
Minimale interventie................................................................................................................................. 18
ASK.............................................................................................................................................. 18
ADVISE........................................................................................................................................ 18
ASSESS (beoordelen)..................................................................................................................18
ASSIST.........................................................................................................................................19
ARRANGE....................................................................................................................................19
REFER......................................................................................................................................... 19
Practicum rookstopconsultatie................................................................................................................. 19
Monotherapie................................................................................................................................19
Patch.................................................................................................................................19
Kauwgom..........................................................................................................................20
Zuigtabletten..................................................................................................................... 20
Inhaler...............................................................................................................................20
Spray................................................................................................................................ 20
Combinatietherapie...................................................................................................................... 20
E-sigaret....................................................................................................................................... 21
Heat not Burn............................................................................................................................... 21
Nicopops.......................................................................................................................................21

,De pathologische long (non-neoplastisch)............................................................................................... 21
Pathologie................................................................................................................................................ 21
Non-neoplastische longziektes.....................................................................................................21
Histologie..................................................................................................................................................22
Wandstructuur.............................................................................................................................. 22
Trachea en grotere bronchi.............................................................................................. 23
Bronchus...........................................................................................................................23
Bronchiolus....................................................................................................................... 23
Longparenchym............................................................................................................................23
Patronen van inflammatie.........................................................................................................................24
Acute inflammatie......................................................................................................................... 24
Resolutie van acute inflammatie.......................................................................................24
Vorming van granulatieweefsel.........................................................................................25
Chronische inflammatie................................................................................................................ 25
Granulomateuze inflammatie........................................................................................................26
Aspiratie pneumonie......................................................................................................... 26
Sarcoïdose = duivenmelkerslong..................................................................................... 26
Respiratoire infecties................................................................................................................................27
Pneumonie................................................................................................................................... 27
Lobaire pneumonie........................................................................................................... 27
Pulmonale tuberculose................................................................................................................. 28
Fungale infecties.......................................................................................................................... 28
Aspergillose...................................................................................................................... 28
Obstructieve luchtweginfecties.................................................................................................................29
Ziekte van de bronchiolus.............................................................................................................29
Ziekte van de bronchus................................................................................................................ 30
Chronische bronchitis....................................................................................................... 30
Bronchiëctasie.................................................................................................................. 30
COPD........................................................................................................................................... 30
Emfyseem.........................................................................................................................31
Asthma......................................................................................................................................... 31
Histopathologie................................................................................................................. 31
Interstitiele longziektes (IDL).................................................................................................................... 32
Acute longbeschadiging............................................................................................................... 32
Diffuse alveolar damage (DAD)........................................................................................ 32
Chronisch diffuse longbeschadiging.............................................................................................33
2 soorten fibrose............................................................................................................... 33
Organising pneumonie................................................................................................................. 34
Pneumoconiosis........................................................................................................................... 34
Asbestose......................................................................................................................... 34
Gecombineerde patronen van longziekten...................................................................................35
Hypersensitieve pneumonitis (HP)................................................................................... 35
Beeldvormings modaliteiten..................................................................................................................... 35
RX vs. CT..................................................................................................................................... 36
RX.................................................................................................................................................36
Standaard thorax-opname................................................................................................ 36
Bedside thorax-opname....................................................................................................36
1

, Anatomie...........................................................................................................................36
CT.................................................................................................................................................37
Verschillende vensters......................................................................................................37
Pulmonaire embolie protocol............................................................................................ 37
Anatomie...........................................................................................................................37
Interpretatie van radiologisch onderzoek................................................................................................. 38
Moeilijkheden bij RX-beelden....................................................................................................... 38
Pathologie – mediastinum........................................................................................................................ 39
Verwijd mediastinum.....................................................................................................................39
Pneumomediastinum....................................................................................................................40
Pneumomediastinum vs. azygos fissure.......................................................................... 41
Pneumoperitoneum...................................................................................................................... 41
Pulmonaire embolie......................................................................................................................41
Pathologie – hilum....................................................................................................................................42
Sarcoïdose................................................................................................................................... 42
Pathologie – bronchiale boom..................................................................................................................43
Pathologie – longparenchym....................................................................................................................43
Atelectase vs. pneumonie............................................................................................................ 44
Pulmonair oedeem....................................................................................................................... 45
Emfyseem.....................................................................................................................................45
Pneumothorax.............................................................................................................................. 46
Tension pneumothorax..................................................................................................... 46
Specifieke infecties.......................................................................................................................46
Tuberculose...................................................................................................................... 47
Aspergillose...................................................................................................................... 47
Pneumocystis jiroveci pneumonie.................................................................................... 47
Pathologie – pleura.................................................................................................................................. 47
Pathologie – bot en weke delen............................................................................................................... 49
Respiratoire insufficiëntie......................................................................................................................... 50
Acute op chronische respiratoire insufficiëntie............................................................................. 50
Bloedgassen.................................................................................................................................50
2 vormen van respiratoire insufficiëntie........................................................................................ 51
Bloedgaswaarden............................................................................................................. 52
Behandeling..................................................................................................................................53
Type I respiratoire insufficiëntie (longinsufficiëntie) → hypoxemie...........................................................53
Diffusiestoornis............................................................................................................................. 53
R-L shunt...................................................................................................................................... 53
V’/Q’ mismatch............................................................................................................................. 54
Klinische verschijnselen van hypoxemie...................................................................................... 54
Type II respiratoire insufficiëntie (ventilatoire insufficiëntie) → hypercapnie............................................ 54
Oorzaken van chronisch adempompfalen.................................................................................... 55
Ademspierzwakte en hypoventilatie................................................................................. 55
Oorzaken van hypercapnie...........................................................................................................55
Klinische verschijnselen van hypercapnie.................................................................................... 56
Zuurstoftherapie....................................................................................................................................... 56
Acute zuurstoftherapie..................................................................................................................56
Bleomycine en zuurstof.................................................................................................... 56
Acuut myocardinfarct en zuurstof..................................................................................... 57
2

, Zuurstoftoediening............................................................................................................ 57
FI, O2 en zuurstoftoediening............................................................................................ 57
Chronische zuurstoftherapie.........................................................................................................58
Zuurstofbesparing: DODS................................................................................................ 59
High flow nasal oxygen therapy (HFNOT/HFNC)............................................................. 59
Beademing............................................................................................................................................... 60
Niet-invasieve ventilatie (NIV)...................................................................................................... 60
Chronische thuisbeademing............................................................................................. 60
Invasieve ventilatie (IV)................................................................................................................ 61
Tracheostomale beademing (TPPV)................................................................................ 61
Traject: duur en wijze van beademing..........................................................................................61
Conclusie..................................................................................................................................................61

Klinische voorbeelden van longlijden (+ zie ppt.).....................................................................................62
Obstructieve longziekten.......................................................................................................................... 62
COPD........................................................................................................................................... 62
Asthma bronchiale........................................................................................................................63
Medicatie.......................................................................................................................... 63
Mucoviscidose.............................................................................................................................. 63
Compressie van buitenaf..............................................................................................................64
Restrictieve longziekten........................................................................................................................... 64
Idiopathische longfibrose..............................................................................................................64
Kyfoscoliose................................................................................................................................. 65
Maligne pleuraal mesothelioom....................................................................................................65
Hypersensitiviteitspneumonitis..................................................................................................... 66
Het respiratoire controlesysteem..............................................................................................................67
Centrale chemoreceptoren........................................................................................................... 67
Perifere chemoreceptoren............................................................................................................ 67
Relatie tussen ventilatie en Pa, CO2............................................................................................68
CO2 ventilatoire controlesysteem.....................................................................................68
Respiratoir ritme genererend centrum..........................................................................................68
Effect van opioïden (bv. morfine)...................................................................................... 69
Pontiene respiratoire groep (PRG, pons)..................................................................................... 69
Hypoglossus motor nucleus......................................................................................................... 69
Overzicht...................................................................................................................................... 69
Vrijwillige ademhaling (motorische cortex)................................................................................... 69
Controle-feedback systeem..........................................................................................................69
Loop gain.......................................................................................................................... 70
Receptoren in de luchtwegen....................................................................................................... 70
Overige receptoren.......................................................................................................................71
Overzicht...................................................................................................................................... 71
Evaluatie ademhalingscontrole................................................................................................................ 71
Directe methoden......................................................................................................................... 71
Indirecte methoden.......................................................................................................................72
Bloedgassen (ABG).......................................................................................................... 72
Slaaponderzoek................................................................................................................73
Pathologische adempatronen........................................................................................... 74
Nachtelijke ademregulatie bij centrale slaapapneu (CSA)....................................................................... 74
3

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller katovandenbroucke. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $17.10. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

78998 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$17.10
  • (0)
  Add to cart